Aiming for Health Equity

The following is a guest article by Hakim Yadi, PhD OBE, Co-Founder and CEO at Closed Loop Medicine Healthcare has historically taken a ‘one size fits all’ approach, which misses the ability to treat all patients as effectively and equitably as possible. Consequently, personalized medicine where treatments are better tailored to a patient has become an aspiration of the modern healthcare system. However, when we look at existing medicines used today, drug therapy is rarely dose optimized for the individual, with most therapies and medical devices approved based on overall safety and efficacy investigated in large-scale clinical trials. These factors not only vary between individuals of different races, gender, age etc., but also in the same person over time. Yet, from 2013-2017, 78% of the drugs approved by the FDA had only one dose regimen and of the drugs considered to be amenable to response-guided treatment, only 39% provided relevant dose instructions. As a result, patient outcomes are affected, not only increasing side effects, medication non-compliance and chronic illness mismanagement, but also higher payor healthcare costs and lost pharma revenue. This perpetuates an ongoing negative care cycle.  Until now, personalized medicine has only been applied to a handful of conditions and is often regarded as the domain of expensive oncological drugs. However, emerging software based medical devices (SaMD) that enable real-time and remote patient monitoring are creating...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Analytics/Big Data C-Suite Leadership Health IT Company Healthcare IT Closed Loop Medicine Digital Healthcare Hakim Yadi PhD OBE Health Equity Hypertension Patient Health Outcomes Personalized Care Personalized Medicine Racial Disp Source Type: blogs